Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection
about
HIV-1 antibodies from infection and vaccination: insights for guiding vaccine designHuman Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesConverting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into playVaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from IndiaHIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities.HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificitiesVaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination.Immunogenetics of small ruminant lentiviral infectionsInnate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls.Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus.The development of CD4 binding site antibodies during HIV-1 infection.The α7-nicotinic receptor is upregulated in immune cells from HIV-seropositive women: consequences to the cholinergic anti-inflammatory responseAntigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion.Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection.HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccineesMolecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity.The Impact of Poxvirus Vector Priming, Protein Co-Administration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques.Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology.Characteristics of Circulating Immune Complexes in HIV-Infected Patients with Different Viral Load.Mathematical model of multivalent virus-antibody complex formation in humans following acute and chronic HIV infections.Computational analysis of antibody dynamics identifies recent HIV-1 infection.A Bistable Switch in Virus Dynamics Can Explain the Differences in Disease Outcome Following SIV Infections in Rhesus Macaques.Correlation Between Anti-gp41 Antibodies and Virus Infectivity Decay During Primary HIV-1 Infection.Frequencies of Circulating Th1-Biased T Follicular Helper Cells in Acute HIV-1 Infection Correlate with the Development of HIV-Specific Antibody Responses and Lower Set Point Viral Load
P2860
Q27022055-A10C84CA-1A1E-4F59-8374-1C4DC0F4210CQ27318508-FBF41C97-085C-4A88-8053-445D83CD67C0Q27468870-4F2B2FB6-860D-49C7-AD7A-5F7265D4DF94Q27675879-3483E38F-05C0-4EDA-A805-39AE46A0CCCCQ28483205-1861A9A8-71F5-4D5C-BF35-93A91CF9CFF1Q33900395-23D9D070-4336-464A-ABB9-F207CCCE0588Q33939974-749C9131-772A-4AF0-A0D6-E67F683C38E4Q33977866-80C80D02-B5AD-470D-946A-563FEA68F8FDQ34434913-BFA9B360-6E59-4C3E-ADEE-54689311D2A4Q35085106-DE487DCC-57FD-4DFD-A028-05ADFBD5F889Q35683986-109E87F0-A606-47C2-BE77-8039C70B205BQ35826158-38AFAF38-30F6-40C8-9EC1-70760C7CE5A5Q35826784-C42AFC96-EA5D-4FCC-9878-2D53A2EC24B7Q36155396-BB546DE0-1D7E-437D-BD22-573EA22AC91CQ36388273-3DD1B197-28FC-4207-8FC6-54CA681A4403Q36559838-F8943A67-11B3-4966-9C69-6F596DBF314CQ36759689-8CD00B56-18A1-47E4-A6E5-58841F36E0B2Q36874604-2C111C6E-18E3-40FA-8EF2-F78D529EA3ACQ36978671-7B5594E8-D6C4-484E-9C7C-4BBAEB8B5A45Q37402557-48D4DD96-C677-4F25-8531-4E5D41081B53Q37714023-CF2FEEF5-6B76-4EDC-A460-CBD39F2A9BB3Q38621582-040849B7-27C5-4B92-B7C7-9B78AA0C8065Q40693941-7720D9CE-A7AB-4A47-BA1C-BE7E1B074637Q40990286-7D2DB07F-ACB9-4402-9926-945BED713E2DQ41752911-E492B19F-7994-4838-BCB7-8756D88B9BBCQ49762357-193197CF-4429-4011-A097-9C3A608766B5Q55361754-44936288-65F7-4C2E-BB46-A931F78A5E10Q55421347-A6C7BC8C-5FE3-47E6-872F-FDA4904A9DF1Q57206379-5A23AA04-7281-4EE3-9B9D-B5A129FD2B71
P2860
Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dynamic antibody specificities ...... ute to chronic HIV-1 infection
@ast
Dynamic antibody specificities ...... ute to chronic HIV-1 infection
@en
type
label
Dynamic antibody specificities ...... ute to chronic HIV-1 infection
@ast
Dynamic antibody specificities ...... ute to chronic HIV-1 infection
@en
prefLabel
Dynamic antibody specificities ...... ute to chronic HIV-1 infection
@ast
Dynamic antibody specificities ...... ute to chronic HIV-1 infection
@en
P2093
P2860
P50
P356
P1433
P1476
Dynamic antibody specificities ...... ute to chronic HIV-1 infection
@en
P2093
Christina Ochsenbauer
Frederik Graw
Georgia D Tomaras
John C Kappes
Nathan Vandergrift
Nicole L Yates
Pinghuang Liu
R Glenn Overman
S Munir Alam
P2860
P304
11196-11207
P356
10.1128/JVI.05601-11
P407
P577
2011-08-24T00:00:00Z